ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00850096

Public ClinicalTrials.gov record NCT00850096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effects of Nasulin v.Placebo on Blood Glucose Control in Patients With Type 2 DM Treated With Basal Insulin & Oral Antidiabetic Meds, Excluding Secretagogues in Phase 2A, Randomized, Parallel, Double-Blind, Placebo-Controlled, Multi-Center Study

Study identification

NCT ID
NCT00850096
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
CPEX Pharmaceuticals Inc.
Industry
Enrollment
94 participants

Conditions and interventions

Interventions

  • Nasulin Drug
  • Placebo for Nasulin Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2008
Primary completion
Feb 28, 2010
Completion
Feb 28, 2010
Last update posted
Dec 12, 2013

2009 – 2010

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Radiant Research Chandler Arizona 85225
AMCR Institute, Inc Escondido California 92026
Scripps Whittier Diabetes Clinic La Jolla California 92037
Mills-Penninsula Health Services; Dorothy & Frank Diabetes Inst. San Mateo California 94401
Diablo Clinical Research Walnut Creek California 94598
Barbara Davis Center Aurora Colorado 80045
Clinical Research of West Florida Clearwater Florida 33765
University of Miami Diabetes Research Institute Miami Florida 33136
Metabolic Research Institute West Palm Beach Florida 33401
Atlanta Diabetes Associates Atlanta Georgia 30309
East-West Medical Research Institute Honolulu Hawaii 96814
Rocky Mountain Clinical Research Idaho Falls Idaho 83404-7596
Maine Research Associates Auburn Maine 04210
Washington University St Louis Missouri 63110
University of Rochester Rochester New York 14642
Mountain Diabetes and Endocrine Center Asheville North Carolina 28803
ECU Diabetes Research Center Greenville North Carolina 27834
Physician's East PA Greenville North Carolina 27834
Texas Diabetes and Endocrinology Austin Texas 78731
University of Texas; Southwestern Medical Center Dallas Texas 75390
Rainier Clinical Research Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00850096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 12, 2013 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00850096 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →